Year
2007
Status
Exited
Team
Field
Oncology diagnostic
Location
Nijmegen (The Netherlands)
Fund
BGV I
NovioGendix
NovioGendix is developing a new biomarker panel for the detection and management of prostate cancer and other cancers. In 2010 MDxHealth acquired NovioGendix.